Amneal Pharmaceuticals (AMRX) Leases (2019 - 2025)
Historic Leases for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Q3 2025 value amounting to $54.4 million.
- Amneal Pharmaceuticals' Leases fell 540.92% to $54.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.4 million, marking a year-over-year decrease of 540.92%. This contributed to the annual value of $56.4 million for FY2024, which is 3038.14% up from last year.
- As of Q3 2025, Amneal Pharmaceuticals' Leases stood at $54.4 million, which was down 540.92% from $55.1 million recorded in Q2 2025.
- Over the past 5 years, Amneal Pharmaceuticals' Leases peaked at $67.5 million during Q1 2021, and registered a low of $43.3 million during Q4 2023.
- Its 5-year average for Leases is $59.7 million, with a median of $60.4 million in 2021.
- As far as peak fluctuations go, Amneal Pharmaceuticals' Leases crashed by 2287.56% in 2023, and later skyrocketed by 3038.14% in 2024.
- Over the past 5 years, Amneal Pharmaceuticals' Leases (Quarter) stood at $60.4 million in 2021, then decreased by 7.04% to $56.1 million in 2022, then dropped by 22.88% to $43.3 million in 2023, then soared by 30.38% to $56.4 million in 2024, then dropped by 3.57% to $54.4 million in 2025.
- Its last three reported values are $54.4 million in Q3 2025, $55.1 million for Q2 2025, and $56.0 million during Q1 2025.